FDA Inspection 810210 — Delcath Systems Inc.

Delcath Systems Inc. — FEI 3009797064

The FDA completed an inspection of Delcath Systems Inc. on Nov 29, 2012 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 29, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748821 CFR 312.59Records of unused drug disposition
750721 CFR 312.52(a)Transfer of obligations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.